|
ZNF420 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.160290E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.063200E-01 |
| Normal-vs-Stage2 |
2.662800E-01 |
| Normal-vs-Stage3 |
3.24259999995302E-06 |
| Normal-vs-Stage4 |
7.00450000001851E-07 |
| Stage1-vs-Stage2 |
1.642160E-01 |
| Stage1-vs-Stage3 |
6.81830000015538E-07 |
| Stage1-vs-Stage4 |
5.48590000093441E-08 |
| Stage2-vs-Stage3 |
7.365900E-02 |
| Stage2-vs-Stage4 |
3.110000E-02 |
| Stage3-vs-Stage4 |
5.374400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.794200E-02 |
| Normal-vs-AfricanAmerican |
9.636500E-04 |
| Normal-vs-Asian |
9.931400E-01 |
| Caucasian-vs-AfricanAmerican |
3.883700E-02 |
| Caucasian-vs-Asian |
5.868400E-01 |
| AfricanAmerican-vs-Asian |
1.741560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.340360E-02 |
| Normal-vs-Female |
5.414400E-02 |
| Male-vs-Female |
7.491600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.862200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.178800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.958800E-03 |
| Normal-vs-Age(81-100Yrs) |
3.920800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.964200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.997800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.895650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.198980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.341500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.990400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.840840E-01 |
| Normal-vs-Grade 2 |
4.292200E-01 |
| Normal-vs-Grade 3 |
8.48840000000628E-05 |
| Normal-vs-Grade 4 |
6.51050324762537E-11 |
| Grade 1-vs-Grade 2 |
3.724200E-01 |
| Grade 1-vs-Grade 3 |
2.256400E-03 |
| Grade 1-vs-Grade 4 |
1.67210000001639E-06 |
| Grade 2-vs-Grade 3 |
6.65740000016513E-07 |
| Grade 2-vs-Grade 4 |
5.00821606408408E-13 |
| Grade 3-vs-Grade 4 |
1.765020E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.268400E-02 |
| Normal-vs-ccB subtype |
1.623930E-04 |
| ccA subtype-vs-ccB subtype |
2.10560000546423E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.051700E-02 |
| Normal-vs-N1 |
9.77909999999582E-05 |
| N0-vs-N1 |
4.328400E-02 |
|
|
